XML 168 R154.htm IDEA: XBRL DOCUMENT v3.20.2
Loans Payable and Loans Payable to Related Parties (Details Narrative) (Brooklyn ImmunoTherapeutics, LLC) (10-K) - USD ($)
1 Months Ended 2 Months Ended 6 Months Ended 7 Months Ended 10 Months Ended 12 Months Ended
Oct. 31, 2018
Dec. 31, 2018
Dec. 31, 2018
Jun. 30, 2020
Jun. 30, 2019
Jul. 31, 2018
Nov. 05, 2018
Dec. 31, 2019
Nov. 07, 2018
Dec. 31, 2017
Equity ownership, percentage               51.00%    
Brooklyn Immunotherapeutics, LLC [Member]                    
Cash   $ 6,325,431 $ 6,325,431 $ 5,186,675 $ 5,586,474     $ 5,014,819    
Interest payable   33,114 33,114 120,677       90,512    
Sale of notes                
Brooklyn Immunotherapeutics, LLC [Member] | Class A Units [Member]                    
Interest payable                 $ 1,516,346  
Shares issued for new issue, value       $ 5,024,313       8,218,762    
Brooklyn Immunotherapeutics, LLC [Member] | Predecessor [Member]                    
Cash             $ 250,296      
Shares issued for new issue, value           $ 31,731        
Equity ownership, percentage           80.00%        
Debt interest rate           14.50%        
Debt maturity date           Dec. 31, 2019        
Sale of notes             1,500,000      
Brooklyn Immunotherapeutics, LLC [Member] | Predecessor [Member] | Board of Directors [Member]                    
Shares issued for new issue, value           $ 11,095,368        
Brooklyn Immunotherapeutics, LLC [Member] | Predecessor [Member] | Predecessor Notes [Member]                    
Promissory notes           19,447,996        
Cash   15,165,816 15,165,816             $ 3,534,000
Interest payable           $ 716,449        
Interest expense             $ 1,652,466      
Brooklyn Immunotherapeutics, LLC [Member] | Predecessor [Member] | Bridge Notes [Member]                    
Interest expense $ 16,346                  
Sale of notes $ 1,500,000                  
Brooklyn Immunotherapeutics, LLC [Member] | Successor [Member]                    
Cash   6,325,431 6,325,431         5,014,819    
Loans payable   410,000 410,000              
Sale of notes                
Brooklyn Immunotherapeutics, LLC [Member] | Successor [Member] | Predecessor Notes [Member]                    
Interest expense   $ 9,121           $ 59,450